Published in JAMA on September 15, 1993
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
Epidemiology of esophageal cancer. World J Gastroenterol (2013) 3.01
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer (2009) 2.33
Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut (2006) 2.28
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut (2004) 1.60
Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut (1999) 1.48
Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut (2000) 1.46
Cancer burden and trends in the Asian Pacific Rim region. Asian Pac J Cancer Prev (2004) 1.39
Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia (2005) 1.38
Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut (2002) 1.38
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer (2008) 1.32
Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut (2003) 1.32
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res (2009) 1.25
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg (2003) 1.23
Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology (2008) 1.19
Oesophageal cancer--an overview. Nat Rev Gastroenterol Hepatol (2013) 1.18
Barrett's oesophagus and proton pump inhibitors: a pathological perspective. Gut (2000) 1.17
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia (2005) 1.12
A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy. J Clin Pathol (2001) 1.10
Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol (2012) 1.06
Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One (2013) 1.05
Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev (2010) 1.05
Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol (2008) 1.04
Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol (2008) 1.03
Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg (1996) 1.01
p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig Dis Sci (1997) 1.01
Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg (1998) 1.00
Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg (2006) 0.99
Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol (2003) 0.97
Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer (2012) 0.96
Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol (2003) 0.95
Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol (2001) 0.95
Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas. Neoplasia (2006) 0.95
Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci (2001) 0.95
Barrett's esophagus. The significance of p53 in clinical practice. Ann Surg (1997) 0.93
Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig Dis Sci (2000) 0.92
Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr Cancer (2009) 0.92
Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS One (2011) 0.91
N-glycan profiling by microchip electrophoresis to differentiate disease states related to esophageal adenocarcinoma. Anal Chem (2012) 0.89
Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J Gastroenterol (2005) 0.88
Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol (2010) 0.88
Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma. J Clin Pathol (2005) 0.88
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut (2003) 0.87
Minimally invasive surgical staging for esophageal cancer. Surg Endosc (2000) 0.87
Barrett esophagus: perspectives on its diagnosis and management in asian populations. Gastroenterol Hepatol (N Y) (2008) 0.86
Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia. World J Gastroenterol (2005) 0.85
Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut (1998) 0.83
The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable? BMC Clin Pathol (2003) 0.81
Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia. J Clin Pathol (2005) 0.80
Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China. World J Gastroenterol (2005) 0.80
The value of traditional upper endoscopy as a diagnostic test for Barrett's esophagus. Gastrointest Endosc (2008) 0.79
The changing profile of esophageal cancer presentation and its implication for diagnosis. J Natl Med Assoc (2007) 0.79
A new approach to endoscopic treatment of tumors of the esophagogastric junction with individually designed self-expanding metal stents. World J Gastroenterol (2008) 0.77
Use of methylene blue for detection of specialized intestinal metaplasia in GERD patients presenting for screening upper endoscopy. Dig Dis Sci (2005) 0.77
Role of Confocal Laser Endomicroscopy in Detection of Residual Barrett's Esophagus after Radiofrequency Ablation. Case Rep Gastrointest Med (2011) 0.76
Endoscopic mucosal resection in the setting of Barrett's esophagus. Can J Gastroenterol (2007) 0.76
Barrett's oesophagus and adenocarcinoma. World J Surg Oncol (2004) 0.76
Circulating Tumor Cells in the Adenocarcinoma of the Esophagus. Int J Mol Sci (2016) 0.76
Surveillance in Barrett's oesophagus: a personal view. Postgrad Med J (2002) 0.75
Short-Segment Barrett's Esophagus and Adenocarcinoma. Gastroenterol Hepatol (N Y) (2006) 0.75
Initial experience with Barrett's strip endoscopic mucosal excision: a new Barrett's excision device. Surg Endosc (2010) 0.75
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Cancer burden in the year 2000. The global picture. Eur J Cancer (2001) 10.47
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Lung cancer. Cancer (1995) 4.50
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
International trends and patterns of prostate cancer incidence and mortality. Int J Cancer (2000) 3.73
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst (1978) 3.01
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol (1983) 2.54
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol (1987) 2.49
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38
Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ (2012) 2.38
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst (2000) 2.35
Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer (2009) 2.33
Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32
Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30
Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst (1989) 2.28
Cancer mortality among chemists. J Natl Cancer Inst (1969) 2.28
Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst (1980) 2.21
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res (1990) 2.21
Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol (2000) 2.18
A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17
Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev (2001) 2.14
Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst (1998) 2.13
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst (1976) 2.11
Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer (1994) 2.09
Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer (1984) 2.07
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Synthetic sweetener consumption and bladder cancer trends in the United States. Nature (1970) 2.05
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer (1996) 2.05
Geographic patterns of oral cancer in the United States: etilogic implications. J Chronic Dis (1977) 2.02
Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst (1987) 2.02
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01